SLNSW-Maintenance Treatment by Erlotinib and Toxic Card...-TN_cdi_karger_primary_OCL2016090003176

Maintenance Treatment by Erlotinib and Toxic Cardiomyopathy: A Case Report

Full title: Maintenance Treatment by Erlotinib and Toxic Cardiomyopathy: A Case Report

Author/creator: Pinquié, François, de Chabot, Gonzagues, Urban, Thierry, Hureaux, José.

Call Numbers:

Record Identifier: TN_cdi_karger_primary_OCL2016090003176

Language: English

Formats: Articles

Publishers: Basel, Switzerland: S. Karger AG

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_karger_primary_OCL2016090003176

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Maintenance Treatment by Erlotinib and Toxic Cardiomyopathy: A Case Report

    Record identifier

    TN_cdi_karger_primary_OCL2016090003176

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_karger_primary_OCL2016090003176

    Share

    Maintenance Treatment by Erlotinib and Toxic Cardiomyopathy: A Case Report

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_karger_primary_OCL2016090003176

    Maintenance Treatment by Erlotinib and Toxic Cardiomyopathy: A Case Report

    Full title

    Maintenance Treatment by Erlotinib and Toxic Cardiomyopathy: A Case Report

    Author / Creator

    Pinquié, François ; de Chabot, Gonzagues ; Urban, Thierry ; Hureaux, José

    Publisher

    Basel, Switzerland: S. Karger AG

    Journal title

    Oncology, 2016, Vol.90 (3), p.176-177

    Record Identifier

    TN_cdi_karger_primary_OCL2016090003176

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Aged Antineoplastic Agents - administration & dosage Antineoplastic Agents - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bundle-Branch Block - complications Cancer Carcinoma, Non-Small-Cell Lung - drug therapy Cardiomyopathy Cardiomyopathy, Dilated - chemically induced Cardiomyopathy, Dilated - physiopathology Cardiomyopathy, Dilated - therapy Cardiovascular diseases Care and treatment Case studies Chemotherapy Cisplatin - administration & dosage Complications and side effects Development and progression Erlotinib Erlotinib Hydrochloride - administration & dosage Erlotinib Hydrochloride - adverse effects Female Humans Lung cancer Lung cancer, Non-small cell Lung Neoplasms - drug therapy Maintenance Chemotherapy - adverse effects Maintenance Chemotherapy - methods Pacemaker, Artificial Pemetrexed - administration & dosage Protein Kinase Inhibitors - administration & dosage Protein Kinase Inhibitors - adverse effects Protein-Tyrosine Kinases - antagonists & inhibitors Short Communication Side effects Stroke Volume - drug effects Toxicity Treatment Outcome

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_karger_primary_OCL2016090003176

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_karger_primary_OCL2016090003176

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections